39777F3A-0854-4C8E-9FF4-9A1369C4733D
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 84.26412614980289
- age_years
- 32
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | 63E967C4-863F-4253-ADFE-3CDC13B6187A | — | — | 0.890 |
| 2 | SRR934863 | — | — | 0.876 |
| 3 | 15838786-D895-4F63-88A9-BDE627AE7958 | — | — | 0.871 |
| 4 | 4880B586-BA92-48B2-A233-5C245D2E31C0 | — | — | 0.871 |
| 5 | AB522ACF-5D84-41B0-9671-CE2511EBD94F | — | — | 0.868 |
| 6 | 4BB9587B-88CB-4BD9-BE1D-2CDF61337579 | — | — | 0.864 |
| 7 | F90967A5-96C6-4669-BCFB-0C51F539B0E7 | — | — | 0.862 |
| 8 | SRR934944 | — | — | 0.861 |
| 9 | 6A30D8D0-DDB8-4B34-8BCB-46986144F551 | — | — | 0.857 |
| 10 | 31A652B1-3BEB-4D78-BCA0-4C153EBC41E8 | — | — | 0.856 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 32 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| MYC_TARGETS_V2 | 0.540 | Idelalisib | — uncovered |
| MYC_TARGETS_V1 | 0.430 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.414 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.379 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.375 | Inavolisib | — uncovered |
| E2F_TARGETS | 0.372 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.363 | Idelalisib | — uncovered |
| DNA_REPAIR | 0.355 | Idelalisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.346 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.344 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.322 | Idelalisib | — uncovered |
| G2M_CHECKPOINT | 0.294 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.266 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.257 | Remibrutinib | — uncovered |
| P53_PATHWAY | 0.239 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.201 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.189 | Inavolisib | — uncovered |
| APOPTOSIS | 0.163 | Idelalisib | — uncovered |
| MTORC1_SIGNALING | 0.146 | Inavolisib | — uncovered |
| GLYCOLYSIS | 0.116 | Inavolisib | — uncovered |